AstraZeneca chief executive Pascal Soriot is reportedly considering moving the company's stock exchange listing from the UK to the US.

Shares in Summit Therapeutics have risen sharply on a report that AstraZeneca is in discussions for a partnership focused on PD-1xVEGF bispecific ivonescimab that is estimated to be worth as much ...

Pharma stocks were hit particularly hard. AstraZeneca and GSK both dropped as US President Donald Trump ramped up the pressure on drugmakers to cut prices in the US. Among earnings, ...

FTSE 100 Live: Pound Slides to Lowest Since May Against Resurgent Dollar ...